Masco Corporation Names Richard Westenberg VP, CFO

Executive Change
Masco Corporation announced the election of Richard (Rick) Westenberg as vice president, chief financial officer (CFO), effective Oct. 16, 2023. Westenberg is a seasoned executive who brings to Masco more than 25 years of experience, in-cluding nearly 15 years leading global finance organizations. Most recently, he served as vice pres-ident and CFO of General Motors North America, overseeing the financial management and finan-cial performance of this approximately $125 billion segment, and leading a team across the U.S., Canada and Mexico. Prior to that, he served as VP, finance and CFO of SAIC-General Motors, GM’s approximately $30 billion joint venture in China, with responsibility as a member of the executive committee for the key operational and strategic decisions of the joint venture. He held roles of increasing respon-sibility during his tenure at GM, including as the corporate treasurer and head of corporate financial planning and analysis. “I am very pleased to welcome Rick to Masco’s leadership team,” said Keith Allman, Masco presi-dent and chief executive officer. “Rick is a strategic, accomplished leader with extensive financial and operational experience. His demonstrated excellence in leading diverse international teams and driving results in a global manufacturing business will be extraordinarily valuable to us as we con-tinue to build upon our strong financial and operational foundation and deliver long-term value for our shareholders.”
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.